Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 10th:
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Immunocore’s shares gained 52% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.7% over the last 60 days.
Catalyst’s shares gained 17.4% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
AmpriusTechnologies, Inc. (AMPX - Free Report) : This ultra-high energy density lithium-ion batteries company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
Amprius’s shares gained 11.5% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 10th:
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Immunocore’s shares gained 52% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.7% over the last 60 days.
Catalyst’s shares gained 17.4% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
AmpriusTechnologies, Inc. (AMPX - Free Report) : This ultra-high energy density lithium-ion batteries company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
Amprius’s shares gained 11.5% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Get the latest research report on CPRX - FREE
Get the latest research report on IMCR - FREE
Get the latest research report on AMPX - FREE